Essence interpretation and hot debates of American Diabetes Association(ADA)Scientific Sessions in 2020
10.3760/cma.j.cn311282-20201123-00780
- VernacularTitle:2020年美国糖尿病学会(ADA)科学年会精粹解读与热点辩论
- Author:
Jin LU
;
Zhaoyun ZHANG
- From:
Chinese Journal of Endocrinology and Metabolism
2021;37(3):180-187
- CountryChina
- Language:Chinese
-
Abstract:
The 80th American Diabetes Association(ADA)Scientific Sessions was held online from June 12 to 16, 2020. There was some hot debates on the topics of diabetes related complications in the annual meeting of ADA. Endocrinologists and cardiologists debated and presented different perspectives. This paper will summarize the debates on the following five topics: (1)Microvascular and macrovascular complications of diabetes are distinct pathophysiologic entities.(2)Guideline recommendations for cardiovascular risk and disease management in type 2 diabetes.(3)Drawing the line between primary and secondary prevention—necessary or too simplistic? (4)Should metformin be considered first-line therapy for individuals with type 2 diabetes with established arteriosclerotic cardiovascular disease(ASCVD)or at high risk for ASCVD? (5)Primary cardiovascular prevention with sodium-glucose co-transporter 2(SGLT2)inhibitors or glucagon-like peptide-1(GLP-1)receptor agonists.
